Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

The Next Biopharma M&A Targets
Barron's
Friday, September 18, 2009 - 11:11am
tags:
M&A, Bristol-Myers Squibb, Eli Lilly, AstraZeneca, Abbott Laboratories, JNJ, Novartis, Sanofi
Drugmaker Sanofi-Aventis buys Merck's half of Merial; step needed for Merck to buy Schering
Yahoo/AP
Friday, September 18, 2009 - 11:01am
tags:
Sanofi, Merck, Merial, veterinary medicine, M&A, Schering Plough
Ambrx, Wyeth ink antibody dev. deal
Fierce Pharma
Friday, September 18, 2009 - 10:57am
tags:
Wyeth, Ambrx, antibody discovery, partnerships
Nycomed makes 4-4.5 bln euro Solvay bid -sources
Reuters
Friday, September 18, 2009 - 10:56am
tags:
Solvay, Nycomed, M&A
Vivus expects to raise $94.5M from stock offering
Yahoo/Zacks.com
Friday, September 18, 2009 - 10:54am
tags:
Vivus, stock offering, Qnexa
Two Positive Notes for Arena Pharmaceuticals
Seeking Alpha
Friday, September 18, 2009 - 8:56am
tags:
Arena Pharmaceuticals, obesity, lorcaserin
Big Pharma's Future Death Spiral?
Seeking Alpha
Friday, September 18, 2009 - 8:55am
tags:
Big Pharma, Merck, Pfizer
Bulls, Bears Fight Over BioCryst
TheStreet.com
Friday, September 18, 2009 - 7:35am
tags:
Biocryst, peramivir
Glaxo Linked Birth Defect of Fetus to Paxil, Ex-Executive Says
Bloomberg
Friday, September 18, 2009 - 7:34am
tags:
GSK, Paxil, birth defects, lawsuits, antidepressants
Pfizer Says Consultant in Drug Cases Tried to Sway Witness
Bloomberg
Friday, September 18, 2009 - 7:33am
tags:
Pfizer, lawsuits, Neurontin, epilepsy
China Aoxing Wins OK for Narcotic Drug Trial
Seeking Alpha
Friday, September 18, 2009 - 7:31am
tags:
China, Aoxing, SFDA, narcotics
Pfizer Paid for Doc's Helicopter in Off-Label Geodon Push, Suit Claims
BNET Pharma
Thursday, September 17, 2009 - 4:49pm
tags:
Pfizer, Geodon, physician payments, Bextra
CDC: 1 in 3 teen girls got cervical cancer vaccine
Yahoo/AP
Thursday, September 17, 2009 - 4:46pm
tags:
cervical cancer, HPV, vaccines, GSK, Merck, Gardasil, Cervarix
Sleepless in Sanofi
Motley Fool
Thursday, September 17, 2009 - 2:15pm
tags:
Sanofi, insomnia, Ciltyri
Pfizer settlement funds whistleblower program
Fierce Pharma
Thursday, September 17, 2009 - 2:13pm
tags:
Pfizer, Florida, settlements, whistleblowers
Drug Stocks Advance; Sequenom Jumps On Launch
WSJ Online
Thursday, September 17, 2009 - 11:28am
tags:
drug stocks, Sequenom
GlaxoSmithKline, Xenoport report positive midstage study results from potential pain drug
Yahoo/AP
Thursday, September 17, 2009 - 11:15am
tags:
GSK, XenoPort, neuropathic pain
J&J, Elan close deal on Alzheimer's program
Reuters
Thursday, September 17, 2009 - 11:12am
tags:
JNJ, Elan, Alzheimer's disease, Janssen Pharmaceuticals
Rituxan tests positive in Phase III trial
Fierce Pharma
Thursday, September 17, 2009 - 11:11am
tags:
Rituxan, Genentech, lymphoma
Drugmaker Merck, British research charity to develop vaccines for diseases in poor countries
Yahoo/AP
Thursday, September 17, 2009 - 11:08am
tags:
Merck, UK, vaccines

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.